Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiovascular (CV) Risk”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Not applicableStudy completedNCT07109011
What this trial is testing

Feasibility, Acceptability, and Validation of a User-friendly Diet Quality Tool in Adults From Ambulatory Nutrition Clinics

Who this might be right for
Weight ManagementCardiovascular (CV) RiskMetabolic and Nutritional Disorders
University of Pennsylvania 122
Post-approval studies (Phase 4)Study completedNCT00428311
What this trial is testing

Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

Who this might be right for
Polycystic Ovary Syndrome
Hospital Universitario Ramon y Cajal 50
Post-approval studies (Phase 4)Ended earlyNCT00879970
What this trial is testing

Thiazolidinedione Intervention With Vitamin D Evaluation

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 1,332
Not applicableLooking for participantsNCT07187947
What this trial is testing

Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

Who this might be right for
Gender IncongruenceCardiovascular (CV) RiskCardiovascular Disease Risk Factor+4 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 500
Large-scale testing (Phase 3)Study completedNCT02104817
What this trial is testing

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Who this might be right for
Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
AstraZeneca 13,078
Large-scale testing (Phase 3)Study completedNCT03814187
What this trial is testing

Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C

Who this might be right for
ASCVDElevated CholesterolHeterozygous Familial Hypercholesterolemia+1 more
Novartis Pharmaceuticals 3,275
Not applicableStudy completedNCT00648284
What this trial is testing

Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects

Who this might be right for
Type 2 Diabetes MellitusCV Risk
GlaxoSmithKline 1,100
Not applicableUnknownNCT04359927
What this trial is testing

Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry

Who this might be right for
Sars-CoV2Covid19Cardiovascular Diseases+1 more
Hospital Clinic of Barcelona 4,538
Not applicableNot Yet RecruitingNCT07703124
What this trial is testing

Female-Specific Modifiers for Healthy Early Action in Cardiovascular Risk Trajectories

Who this might be right for
Perimenopausal WomenPostmenopausal Female PatientsCardiovascular (CV) Risk
Ludwig Boltzmann Institute for Cardiovascular Research 605
Not applicableLooking for participantsNCT07760662
What this trial is testing

Oxidative Stress and Cardiovascular Risk in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RAOxidative StressCardiovascular (CV) Risk
University of La Laguna 200
Not applicableStudy completedNCT01853839
What this trial is testing

Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk Patients

Who this might be right for
Hypertension
Boehringer Ingelheim 1,674
Large-scale testing (Phase 3)Study completedNCT01516541
What this trial is testing

Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Who this might be right for
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Hoffmann-La Roche 2,220
Not applicableLooking for participantsNCT07809932
What this trial is testing

Breast Artery Calcification (BAC) and Female Cardiovascular Disease

Who this might be right for
Cardiovascular Health Risk CommunicationCardiovascular (CV) RiskCardiovascular Disease Prevention
Northwell Health 200
Testing effectiveness (Phase 2)Looking for participantsNCT07223385
What this trial is testing

High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

Who this might be right for
Prostate Cancer (Diagnosis)Prostate Cancer Stage IVCV Risk
Cedars-Sinai Medical Center 80
Large-scale testing (Phase 3)Study completedNCT01709513
What this trial is testing

Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)

Who this might be right for
Hypercholesterolemia
Regeneron Pharmaceuticals 314
Not applicableLooking for participantsNCT06202820
What this trial is testing

CV CARE: CardioVascular Care in PC Patients

Who this might be right for
Prostate CancerCardiovascular Diseases
Dana-Farber Cancer Institute 180
Post-approval studies (Phase 4)Looking for participantsNCT05152888
What this trial is testing

The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk

Who this might be right for
Stable Coronary Disease
Brigham and Women's Hospital 50
Not applicableStudy completedNCT07205237
What this trial is testing

Effect of Eliminating Red Meat Consumption on the Cardiovascular System

Who this might be right for
Cardiovascular (CV) Risk
Maria Clara Rocha 12
Not applicableStudy completedNCT01636271
What this trial is testing

SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033)

Who this might be right for
Coronary Heart Disease
GlaxoSmithKline 28,855
Not applicableNot Yet RecruitingNCT07137182
What this trial is testing

The Effect of Physical Activity on Cardiovascular Disease Risk Awareness and Self-Worth in Young Women

Who this might be right for
Cardiovascular (CV) RiskPhysical Activities
Karamanoğlu Mehmetbey University 60
Next Page